Poynt Corporation/ CA73942D1096 /
17/11/2023 19:28:57 | Var. - | Volume | Denaro- | Lettera- | Max | Min |
---|---|---|---|---|---|---|
0.0000USD | - | 156,250 Fatturato: .1563 |
-Quantità in denaro: - | -Quantità in lettera: - | 0.0000 | 0.0000 |
GlobeNewswire
08:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
08:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
08:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
08:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
08:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents